Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, ImmunityBio Inc’s stock clocked out at $3.44, down -2.27% from its previous closing price of $3.52. In other words, the price has decreased by -$2.27 from its previous closing price. On the day, 2.89 million shares were traded. IBRX stock price reached its highest trading level at $3.53 during the session, while it also had its lowest trading level at $3.35.

Ratios:

To gain a deeper understanding of IBRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.88 and its Current Ratio is at 3.91.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 12, 2023, Downgraded its rating to Neutral and sets its target price to $4 from $10 previously.

On August 03, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $8.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IBRX now has a Market Capitalization of 2396073472 and an Enterprise Value of 3233785600. For the stock, the TTM Price-to-Sale (P/S) ratio is 1829.06. Its current Enterprise Value per Revenue stands at 2472.313 whereas that against EBITDA is -9.482.

Stock Price History:

Over the past 52 weeks, IBRX has reached a high of $10.53, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is -22.70%, while the 200-Day Moving Average is calculated to be -33.89%.

Shares Statistics:

It appears that IBRX traded 3.02M shares on average per day over the past three months and 2810430 shares per day over the past ten days. A total of 670.87M shares are outstanding, with a floating share count of 159.51M. Insiders hold about 77.10% of the company’s shares, while institutions hold 8.85% stake in the company. Shares short for IBRX as of 1724976000 were 51291516 with a Short Ratio of 16.96, compared to 1722384000 on 46767532. Therefore, it implies a Short% of Shares Outstanding of 51291516 and a Short% of Float of 31.790000000000003.

Most Popular